Kolexia
Merabet Fatiha Hématologie
Merabet Fatiha
Hématologie
Centre hospitalier de Versailles
Le Chesnay, France
68 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie lymphoïde Leucémie chronique lymphocytaire à cellules B Macroglobulinémie de Waldenström COVID-19 Leucémie aigüe myéloïde Leucémie myéloïde Lymphomes Leucémie prolymphocytaire

Collaborateurs

Voir plus
Besson Caroline
Besson Caroline
Centre hospitalier de Versailles, Le Chesnay, France
Taksin-Bressot Anne-Laure
Taksin-Bressot Anne-Laure
Centre hospitalier de Versailles, Le Chesnay, France
Rousselot Philippe
Rousselot Philippe
Hôpital Saint-Louis, Paris, France
Farhat Hassan Yann
Farhat Hassan Yann
Centre hospitalier de Versailles, Le Chesnay, France

Industries

Voir plus
A+A
36 collaboration(s)
Dernière en 2023
Abbvie
14 collaboration(s)
Dernière en 2023
AstraZeneca
9 collaboration(s)
Dernière en 2023
Amgen
8 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group
65th ASH Annual Meeting Abstracts   02 novembre 2023
EVEREST: Assessment of the Quality of Life of Patients With Lymphomas Treated With Oral Therapy
Essai Clinique (CHU Toulouse)   18 septembre 2023
SérieProWM: Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease: Validation of International Prognostic Indexes, Evaluation of Progression-free Survival as a Surrogate Endpoint for Overall Survival
Essai Clinique (French Innovative Leukemia Organisation)   28 août 2023
STAIR: STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia
Essai Clinique (French Innovative Leukemia Organisation)   23 mai 2023
PO138 EMICIZUMAB TREATMENT IN PATIENT WITH ACQUIRED HEMOPHILIA CAN BE A RELAY TO BYPASSING AGENTS: A CASE REPORT
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO)
Annual Meeting Abstracts 2022   15 novembre 2022
Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)
Annual Meeting Abstracts 2022   15 novembre 2022
Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation
Annual Meeting Abstracts 2022   15 novembre 2022
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia.
Blood advances   23 juin 2022